Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Croatian guidelines for the management of hyperprolactinemia: a viewpoint from a developing country (CROSBI ID 232119)

Prilog u časopisu | pregledni rad (znanstveni)

Marinković Radošević, Jelena ; Kirigin, Lora ; Strinović, Mateja ; Kruljac, Ivan ; Perić, Božidar ; Mirošević, Gorana ; Stipić, Darko ; Bokulić, Adriana ; Čerina, Vatroslav ; Pećina, Hrvoje Ivan et al. Croatian guidelines for the management of hyperprolactinemia: a viewpoint from a developing country // Endocrine oncology and metabolism, 1 (2015), 1; 10-23

Podaci o odgovornosti

Marinković Radošević, Jelena ; Kirigin, Lora ; Strinović, Mateja ; Kruljac, Ivan ; Perić, Božidar ; Mirošević, Gorana ; Stipić, Darko ; Bokulić, Adriana ; Čerina, Vatroslav ; Pećina, Hrvoje Ivan ; Gregurić, Tomislav ; Bukovec Megla, Željka ; Radman, Maja ; Crnčević Orlić, Željka ; Klobučar Majanović, Sanja ; Miškić, Blaženka ; Jandrić Balen, Marica ; Tvrdeić, Ante ; Bakula, Miro ; Rahelić, Dario ; Krnić, Mladen ; Kčira Fideršek, Vječeslav ; Vrkljan, Milan

engleski

Croatian guidelines for the management of hyperprolactinemia: a viewpoint from a developing country

Objectives: Hyperprolactinemia is a common endocrine problem seen in everyday practice. Therefore, the Croatian society for endocrine oncology decided to write Croatian guidelines for the management of hyperprolactinemia that implements current scientific evidence with acknowledgement of economic and cultural specificities in Croatia. Methods: These guidelines were written by a Working group in the Croatian society for endocrine oncology, which included experts from different medical specialities that manage hyperprolactinemia, and were based on relevant scientific data. Results: These guidelines provide a comprehensive review of prolactin pathophysiology, the aetiology of hyperprolactinemia, as well as recommendations for the diagnostic and therapeutic approach to patients with hyperprolactinemia. Conclusion: These practical guidelines are in agreement with current scientific knowledge and will ensure better management of hyperprolactinemia in Croatia.

Croatia ; developing ; country ; hyperprolactinemia ; prolactinoma ; management ; guidelines

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

1 (1)

2015.

10-23

objavljeno

1849-8922

1849-9031

Povezanost rada

Kliničke medicinske znanosti